Additional t(1;11)(q21;q23) with mixed lineage leukemia rearrangement in T-blastic crisis of a Ph-positive chronic myeloid leukemia [3]

European Journal of Haematology

Volumn 79, Issue 2, 2007, Pages 179-181

  Otero, Luize ^a,b   Moellmann, Arthur C ^a   Pombo De Oliveira, Maria S ^a   Ornellas, Maria Helena ^a,b   Pires, Virgínia ^a   Bouzas, Luis Fernando ^a   Fernandez, Teresa De Souza ^a,b  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN;

BLAST CELL CRISIS; BONE MARROW CELL; CELL CYCLE; CELL PROLIFERATION; CHROMOSOME 21Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHRONIC MYELOID LEUKEMIA; DISEASE COURSE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; LETTER; LYMPHOCYTIC INFILTRATION; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; BLAST CRISIS; CELL LINEAGE; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 11; FEMALE; HUMANS; KARYOTYPING; LEUKEMIA, MYELOID, CHRONIC; PHILADELPHIA CHROMOSOME;

EID: 34447309617     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2007.00884.x     Document Type: Letter

References (24)

1. Heim S, Mitelman F. Chronic myeloid leukemia. In : Heim S, Mitelman F, eds. Cancer Cytogenetics. New York : Wiley-Liss, 1995 : 33 68.
2. Griesshammer M, Heize B, Bangerter M, Heimpel H, Fliedner TM. Karyotype abnormalities and their clinical significance in blast crisis at chronic myeloid leukemia. J Mol Med 1997 75 : 836 8.
3. Shteper PJ, Ben-Yehuda D. Molecular evolution of chronic myeloid leukemia. Semin Cancer Biol 2001 11 : 313 23.
4. ISCN (2005) : An International System for Human Cytogenetic Nomenclature. Shaffer LG, Tommerup N, eds. Basel : S. Karger, 2005.
5. Otazú IB, Zalcberg I, Tabak DG, Dobbin J, Seuanez HN. Detection of BCR-ABL transcripts by multiplex and nested PCR in different haematological disorders. Leuk Lymphoma 2000 37 : 205 11.
6. Secker-Walker LM, Craig JM. Prognostic implications of breakpoint and lineage heterogeneity in Philadelphia-positive acute myeloid leukemia: review. Leukemia 1993 7 : 147 51.
7. Ye CC, Echeverri C, Anderson JE, Smith JL, Glassman A, Gulley ML, Claxton D, Craig FE. T-cell blast crisis of chronic myelogenous leukemia manifesting as a large mediastinal tumor. Hum Pathol 1993 33 : 770 3.
8. Silva MLM, Fernandez TS, Souza MHO, Soares RPM, Sá LA, Dobbin J, Klumb C, Tabak D, Ribeiro RC, Abdelhay E. M-BCR rearrangement in a case of T-cell childhood acute lymphoblastic leukemia. Med Pediatr Oncol 1999 32 : 455 6.
9. Mitelman F. Catalog of Chromosome Aberrations in Cancer, 5th ed. New york : Wiley-Liss Inc., 1999.
10. Sorensen PHB, Chen CS, Smith FO, Arthur DC, Domer PH, Berstein ID, Korsmeyer SJ, Hammond GD, Kersey JH. Molecular rearrangements on the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes. J Clin Invest 1999 93 : 429 37.
11. Ishii E, Kawasaki H, Isoyama K, Eguchi-Ishimae M, Eguchi M. Recent advances in the treatment of infant acute myeloid leukemia. Leuk Lymphoma 2003 44 : 741 8.
12. Suzuki K, Sugawara T, Kowata S, Utsugizawa T, Ito S, Murai K, Ishida Y. Uncommon karyotype abnormality, t(11;19)(q23;p13.3), in a patient with blastic phase of chronic myeloid leukemia. Cancer Genet Cytogenet 2004 150 : 159 63.
13. Royer-Pokora B, Hildebrandt B, Redmann A, Herold C, Kronenwett R, Haas R, Drechsler M, Wieland C. Simultaneous occurrence of a t(9;22) (Ph) with a t(2;11) in a patient with CML and emergence of a new clone with the t(2;11) alone after imatinib mesylate treatment. Leukemia 2003 17 : 807 10.
14. Nishi K, Usui E, Sakakura M, et al. Additional t(11;17)(q23;q21) in a patient with Philadelphia-positive mixed lineage antigen-expressing leukemia. Cancer Genet Cytogenet 2001 126 : 8 12.
15. Dierlamm J, Stefanova M, Michaux L, Lincke E, Leberecht P, Hossfeld DK. Unusual clinical course and acquisition of del(11)(q23) in second lymphatic blastic phase of a Ph-positive chronic myeloid leukemia. Cancer Genet Cytogenet 1999 113 : 85 89.
16. Li L, Ritterbach J, Harbott J, Schroyens W, Lohmeyer J, Pralle H, Lampert F. Blastic phase chronic myeloid leukemia with a four-break rearrangement: t(11;9)(9;22)(q23;p22;q34;q11). Cancer Genet Cytogenet 1993 68 : 131 4.
17. Dastugue N, Duchayne E, Huguet F, Demur C, Plaisancie H, Calvas P, Bourrouillou G, Pris J, Colombies P. t(9;11)(p22;q23) translocation in blastic phase of chronic myeloid leukemia. Cancer Genet Cytogenet 1992 63 : 37 42.
18. Sessarego M, Frassoni F, Defferrari R, Bacigalupo A, Fugazza G, Mareni C, Bruzzone R, Dejana A, Ajmar F. Karyotype evolution of Ph positive chronic myelogenous leukemia patients relapse in advanced phases of the disease after allogeneic bone marrow transplantation. Cancer Genet Cytogenetic 1991 57 : 69 78.
19. Singh S, Wass J, Vincent PC, Young GA, Gunz FW. Significance of secondary cytogenetic changes in patients with Ph-positive chronic granulocytic leukemia in the acute phase. Cancer Genet Cytogenet 1986 21 : 209 20.
20. Cuneo A, Barbieri D, Ferraresi P, Castoldi GL. A case of chronic myelogenous leukemia with 11q- in blast crisis with monoblastic differentiation. Nouv Rev Fr Hematol 1985 27 : 389 91.
21. Meyer C, Schneider B, Reichel M, et al. Diagnostic tool for the identification of MLL rearrangements including unknown partner genes. Proc Natl Acad Sci USA 2005 102 : 449 54.
22. Tse W, Meshinchi S, Alonzo TA, Stirewalt DL, Gerbind RB, Woods WG, Appelbaum FR, Radich JP. Elevated expression of the AF1q gene, an MLL fusion partner, is an independent adverse prognostic factor in pediatric acute myeloid leukemia. Blood 2004 104 : 3058 63.
23. Tse W, Deeg J, Stirewalt D, Appelbaum FR, Radich J, Gooley T. Increased AF1q gene expression in high-risk myelodysplastic syndrome. Br J Haematol 2005 128 : 218 20.
24. Calabretta B, Perroti D. The biology of CML blast crisis. Blood 2004 103 : 4010 22.